Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul;46(5):470-7.
doi: 10.1002/eat.22104.

Biological therapies for eating disorders

James E Mitchell  1 , James Roerig, Kristine Steffen
Affiliations
Review

Biological therapies for eating disorders

James E Mitchell et al. Int J Eat Disord. 2013 Jul.

Abstract

Objective: To provide a comprehensive review of pharmacotherapy and other biological treatments for eating disorders.

Method: Literature on this topic was systematically reviewed.

Results: The bulimia nervosa (BN) literature underscores the utility of antidepressants, particularly SSRIs, in improving the symptoms of the disorder. The literature on binge eating disorder supports efficacy on reduction in binge eating frequency for a variety of compounds. However, such compounds have only modest effects on weight. Certain antiepileptic agents such as topiramate, if tolerated, are probably more useful in terms of weight loss. The number of controlled trials in patients with anorexia nervosa (AN) in particular has been quite small, and recent meta-analyses show disappointing results using atypical antipsychotics in AN.

Discussion: The pharmacological treatment of eating disorders remains an underdeveloped field although drug therapy clearly plays a role in the treatment of those with BN and binge eating disorder. Other biological therapies have not been adequately studied.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest were reported for any of the authors.

Comment in

References

    1. Aigner M, Treasure J, Kay W, Kasper S WFSBT Task Force on Eating Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the pharmacological treatment of eating disorders. W J Bio Psychiatry. 2011;12:400–443. - PubMed
    1. McElroy SL, Guerdjikova AI, Mori N, O’Melia AM. Pharmacological management of binge eating disorder: Current and emerging treatment options. Ther Clin Risk Manag. 2012;8:219–241. - PMC - PubMed
    1. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry. 1992;49:139–147. - PubMed
    1. Steinhausen HC, Weber S. The outcome of bulimia nervosa: findings from one-quarter century of research. Am J Psychiatry. 2009;166:1331–41. Epub 2009 Nov 2. - PubMed
    1. Bacaltchuk J, Hay PPJ. Antidepressants versus placebo for people with bulimia nervosa. Cochrane Database of Systematic Reviews. 2003;(4) - PMC - PubMed

Publication types

MeSH terms